Vividion nabs ex-Pfizer R&D head Abraham; Lu takes CMO role at Pharvaris; Enterprise taps Morris as medical head.
Pfizer’s longtime cancer research head Robert Abraham, Ph.D., has become the new chief scientific officer at a San Diego biotech.
There is a significant amount of work being done on cardiovascular diseases. Here’s a look at just some of the recent news.
*|RSSFEED:DATE|* Incase you missed it. We summarize the week's top biotechnology stories.
Stilla Technologies has raised a €20M Series C round to fund its mission to produce next-generation microchips that make molecular diagnostics more precise and user-friendly than currently ...
Two Big Pharmas have decided to walk away from two small biotech deals after disappointing trial results: Pfizer from GlycoMimetics and Merck from KalVista Pharmaceuticals.
The industry’s reliance on China-based firms for chemistry services is in the spotlight
The FDA has placed a clinical hold on LogicBio Therapeutics’ planned genome editing trial. LogicBio wants to trial the therapy in methylmalonic acidemia patients aged two years and up but ...